Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress

Behavioural Brain Research

Volumn 224, Issue 2, 2011, Pages 305-310

  Baluchnejadmojarad, Tourandokht ^a   Roghani, Mehrdad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Diabetic rat; Epigallocatechin 3 gallate; Learning and memory; Spatial recognition memory

Indexed keywords

7 NITROINDAZOLE; ARGININE; EPIGALLOCATECHIN GALLATE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECALL; SCORING SYSTEM; STREPTOZOCIN DIABETES; TASK PERFORMANCE;

ANIMALS; AVOIDANCE LEARNING; BLOOD GLUCOSE; BODY WEIGHT; CATECHIN; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; INDAZOLES; LEARNING DISORDERS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; NITRITES; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 80051799595     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.06.007     Document Type: Article

References (49)

1. Manschot S.M., Biessels G.J., Rutten G.E., Kessels R.P., Gispen W.H., Kappelle L.J. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J Neurol Sci 2008, 264:157-162.
2. Kennedy J.M., Zochodne D.W. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005, 10:144-157.
3. Jin H.Y., Liu W.J., Park J.H., Baek H.S., Park T.S. Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch Med Res 2009, 40:536-544.
4. Carlsson C.M. Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis 2010, 20:711-722.
5. Roriz-Filho S., Sa-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L., et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
6. Wrighten S.A., Piroli G.G., Grillo C.A., Reagan L.P. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta 2009, 1792:444-453.
7. Kucukatay V., Agar A., Gumuslu S., Yargicoglu P. Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: relation to oxidant stress and antioxidant enzymes. Int J Neurosci 2007, 117:1091-1107.
8. Stranahan A.M., Lee K., Pistell P.J., Nelson C.M., Readal N., Miller M.G., et al. Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels. Neurobiol Learn Mem 2008, 90:479-483.
9. Iwai T., Suzuki M., Kobayashi K., Mori K., Mogi Y., Oka J. The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1. Neurosci Res 2009, 64:67-74.
10. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998, 7:351-354.
11. Guo Q., Zhao B., Li M., Shen S., Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1996, 1304:210-222.
12. Fu Z., Zhen W., Yuskavage J., Liu D. Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br J Nutr 2010, 1-8.
13. Roghani M., Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010, 17:55-59.
14. Kandinov B., Giladi N., Korczyn A.D. Smoking and tea consumption delay onset of Parkinson's disease. Parkinsonism Relat Disord 2009, 15:41-46.
15. Kim T.I., Lee Y.K., Park S.G., Choi I.S., Ban J.O., Park H.K., et al. l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 2009, 47:1601-1610.
16. Mandel S.A., Amit T., Weinreb O., Reznichenko L., Youdim M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther 2008, 14:352-365.
17. Kang K.S., Wen Y., Yamabe N., Fukui M., Bishop S.C., Zhu B.T. Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. PLoS One 2010, 5:e11951.
18. Weinreb O., Amit T., Mandel S., Youdim M.B. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 2009.
19. Dasilva K.A., Shaw J.E., McLaurin J. Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention. Exp Neurol 2010, 223:311-321.
20. Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 2008, 1214:177-187.
21. Tiwari V., Kuhad A., Chopra K. Epigallocatechin-3-gallate ameliorates alcohol-induced cognitive dysfunctions and apoptotic neurodegeneration in the developing rat brain. Int J Neuropsychopharmacol 2010, 13:1053-1066.
22. Haque A.M., Hashimoto M., Katakura M., Tanabe Y., Hara Y., Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006, 136:1043-1047.
23. Okamoto H. Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic b-cells of islets of Langerhans. Bioessays 1985, 2:15-21.
24. Elsner M., Guldbakke B., Tiedge M., Munday R., Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000, 43:1528-1533.
25. Kumar P., Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 2009, 47:2522-2530.
26. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005, 25:8807-8814.
27. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., et al. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 2002, 24:695-701.
28. Baluchnejadmojarad T., Roghani M. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology 2006, 78:193-197.
29. Bagheri M., Joghataei M.T., Mohseni S., Roghani M. Genistein ameliorates learning and memory deficits in amyloid beta((1-40)) rat model of Alzheimer's disease. Neurobiol Learn Mem 2011, 95:270-276.
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
31. Alvarez E.O., Beauquis J., Revsin Y., Banzan A.M., Roig P., De Nicola A.F., et al. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2009, 198:224-230.
32. Frier B.M. Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited. Diabetologia 2011, 54:233-236.
33. Comin D., Gazarini L., Zanoni J.N., Milani H., de Oliveira R.M., Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats. Behav Brain Res 2010, 210:38-45.
34. Kucukatay V., Hacioglu G., Ozkaya G., Agar A., Yargicoglu P. The effect of diabetes mellitus on active avoidance learning in rats: the role of nitric oxide. Med Sci Monit 2009, 15:BR88-93.
35. Chae C.H., Jung S.L., An S.H., Park B.Y., Wang S.W., Cho I.H., et al. Treadmill exercise improves cognitive function and facilitates nerve growth factor signaling by activating mitogen-activated protein kinase/extracellular signal-regulated kinase1/2 in the streptozotocin-induced diabetic rat hippocampus. Neuroscience 2009, 164:1665-1673.
36. Sposato V., Manni L., Chaldakov G.N., Aloe L. Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain. Arch Ital Biol 2007, 145:87-97.
37. Wang X., Zheng W., Xie J.W., Wang T., Wang S.L., Teng W.P., et al. Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener 2010, 5:46.
38. Cai Z., Zhao Y., Yao S., Bin Zhao B. Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation. Pharmacol Rep 2011, 63:381-391.
39. Brands A.M., Biessels G.J., de Haan E.H., Kappelle L.J., Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735.
40. Fukui K., Omoi N.O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., et al. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci 2002, 959:275-284.
41. Baluchnejadmojarad T., Roghani M., Nadoushan M.R., Bagheri M. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model. Phytother Res 2009, 23:132-135.
42. Hawkins C.L., Davies M.J. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001, 1504:196-219.
43. Rasoolijazi H., Joghataie M.T., Roghani M., Nobakht M. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iran Biomed J 2007, 11:237-243.
44. Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002, 946:221-231.
45. Rrapo E., Zhu Y., Tian J., Hou H., Smith A., Fernandez F., et al. Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice. Am J Transl Res 2009, 1:72-79.
46. Gundimeda U., McNeill T.H., Schiffman J.E., Hinton D.R., Gopalakrishna R. Green tea polyphenols potentiate the action of nerve growth factor to induce neuritogenesis: possible role of reactive oxygen species. J Neurosci Res 2010, 88:3644-3655.
47. Meng F., Abedini A., Plesner A., Verchere C.B., Raleigh D.P. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 2010, 49:8127-8133.
48. Weinreb O., Amit T., Youdim M.B. The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate. Arch Biochem Biophys 2008, 476:152-160.
49. Kupershmidt L., Weinreb O., Amit T., Mandel S., Carri M.T., Youdim M.B. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 2009, 23:3766-3779.